NASDAQ · ADAG
Adagene financials
$3.21+0.31%
Close Sep 29, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Fiscal year | FY25 Dec 31 | FY24 Dec 31 | FY23 Dec 31 | FY22 Dec 31 | FY21 Dec 31 |
|---|---|---|---|---|---|
| Revenue | $7.7M | $103.2K | $18.1M | $9.3M | $10.2M |
| Gross profit | $7.7M | $103.2K | $18.1M | $9.3M | $10.2M |
| Gross margin | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% |
| Operating income | -$21.4M | -$36.0M | -$23.7M | -$83.9M | -$72.4M |
| Net income | -$17.6M | -$33.4M | -$18.9M | -$80.0M | -$73.2M |
| Net margin | −229.6% | −32386.4% | −104.6% | −860.6% | −719.5% |
| Diluted EPS | $-0.30 | $-0.59 | $-0.35 | $-1.48 | $-1.46 |
| EBITDA | -$21.0M | -$35.2M | -$22.7M | -$82.8M | -$71.2M |
| Operating cash flow | -$15.7M | -$29.7M | -$28.5M | -$48.6M | -$43.4M |
| Free cash flow | -$15.7M | -$29.7M | -$28.5M | -$49.3M | -$45.9M |
| Diluted shares | 59.0M | 56.3M | 54.7M | 54.1M | 50.0M |
Balance sheet
| Period end | Dec 31 | Dec 31 | Dec 31 | Dec 31 | Dec 31 |
|---|---|---|---|---|---|
| Cash & equivalents | $74.5M | $85.2M | $109.9M | $143.8M | $174.4M |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Total debt | $6.1M | $18.2M | $21.9M | $27.8M | $7.5M |
| Total assets | $78.3M | $89.3M | $115.7M | $152.4M | $189.5M |
| Total liabilities | $26.4M | $38.7M | $45.2M | $69.3M | $33.0M |
| Shareholders' equity | $35.3M | $50.5M | $70.6M | $83.1M | $156.6M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology